Holen Sie sich die Stockscreener-App
0.3496
4.08%
0.0137
Handel nachbörslich:
.35
0.0004
+0.11%
Schlusskurs vom Vortag:
$0.3359
Offen:
$0.3289
24-Stunden-Volumen:
1.85M
Relative Volume:
0.51
Marktkapitalisierung:
$35.18M
Einnahmen:
$69.49M
Nettoeinkommen (Verlust:
$-21.13M
KGV:
-0.5387
EPS:
-0.649
Netto-Cashflow:
$-14.46M
1W Leistung:
+1.13%
1M Leistung:
+37.85%
6M Leistung:
+16.53%
1J Leistung:
-67.33%
1-Tages-Spanne:
$0.3289
$0.3554
1-Wochen-Bereich:
$0.2936
$0.3554
52-Wochen-Spanne:
$0.1616
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Firmenname
Cosmos Health Inc
Sektor
Branche
Telefon
312-536-3102
Adresse
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.3496 | 35.18M | 69.49M | -21.13M | -14.46M | -0.649 |
MCK
Mckesson Corp
|
955.76 | 111.43B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
325.06 | 62.03B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
238.08 | 55.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.23 | 9.39B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.37 | 1.17B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc Aktie (COSM) Neueste Nachrichten
Cosmos Health Reports Record $17.4 Million Q3 Revenue - Quiver Quantitative
Cosmos Health reports record ~$54.3M nine-month revenue; Q3 ~$17.4M, reaffirms >$90M 2026 outlook - TradingView
Cosmos Health Inc. Reaffirms Revenue Guidance for Fiscal 2026 - www.marketscreener.com
Cosmos Health sees revenue of about $54.3M for the nine months ended Sept 30 - TradingView
Cosmos Health Q3 revenue rises to record high on contract manufacturing - TradingView
Cosmos Health posts $54.3M in nine-month revenue, up 19% - StreetInsider
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million - Stock Titan
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million - Yahoo! Finance Canada
Cosmos Health Inc. (COSM) Posts Record 9M Revenue $54.3M, Reaffirms >$90M 2026 Outlook - TradingView
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million - Morningstar
COSM Continues to Surge Revenue Growth - Yahoo Finance
Cosmos Health Inc (V67A.SG) stock price, news, quote and history - Yahoo Finance Australia
Cosmos Health Inc. Advanced Charts | COSM - Barron's
Cosmos Health stock fell 1.58 percent as brands expand globally - AD HOC NEWS
Cosmos Health Inc.Common Stock (Nasdaq:COSM) Stock Quote - FinancialContent
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion - Morningstar
Price to sales ratio of Cosmos Health Inc – HAN:V67A - TradingView
Total liabilities of Cosmos Health Inc – HAN:V67A - TradingView
COSM Continues to Grow Business - Yahoo Finance
COSM Forecast — Price Target — Prediction for 2027 - TradingView
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue - USA Today
Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue - Investing.com
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue - marketscreener.com
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue - Newswire.com
Robots and AI could let Cosmos Health's pharmacy distributor handle over $100 million in annual sales - Stock Titan
Cosmos Health Inc. (COSM) Says CosmoFarm Run-Rate Tops $60M; Adds Capacity Toward $100M+ - TradingView
Cosmos Health Inc. (COSM) Stock Price, News, Quote & History - ca.finance.yahoo.com
Cosmos Health Subsidiary Cana Laboratories Secures $20M Contract Manufacturing Pipeline (COSM) - GuruFocus
Cosmos Health’s Cana unit surpasses $20M CMO pipeline - Investing.com
An Athens factory's production pipeline exceeds 32.7 million units, with contracts up to 10 years. - Stock Titan
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline - Yahoo Finance
Cosmos Health Inc. (COSM) CMO Pipeline Implies $20M Revenue, $18M Gross Profit - TradingView
Cosmos Health Inc. (COSM) CMO Pipeline Implies $20M Revenue, $18M Gross Profit - TradingView
Why Did SOC, HTZ, COSM Stocks Tumble To 52-Week Lows? - Stocktwits
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June - Yahoo Finance
A weight-management capsule’s gel expands more than 100-fold. Cosmos Health proposes funding it without new shares. - Stock Titan
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market - Yahoo Finance
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com South Africa
Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar - TradingView
COSM Looks 10.4% Undervalued on GF Value™ Amid Contract Manufact - GuruFocus
Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine - Bitget
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com UK
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units - ACCESS Newswire
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units - Yahoo Finance
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market - webull.com
COSM Looks 8.2% Undervalued on GF Value™ Amid Challenging Fundam - GuruFocus
Cosmos Health receives first orders for veterinary product line - Investing.com
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market - Fidelity Investments
Cosmos Health buyback reaches 5.11 million shares under $5 million program - scanx.trade
Finanzdaten der Cosmos Health Inc-Aktie (COSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cosmos Health Inc-Aktie (COSM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jul 29 '26 |
Buy |
0.18 |
766,284 |
140,000 |
14,248,092 |
| Terzis Georgios | Chief Financial Officer |
Jun 16 '26 |
Buy |
0.25 |
168,135 |
42,000 |
2,235,398 |
| Siokas Grigorios | Chief Executive Officer |
Jun 11 '26 |
Buy |
0.21 |
218,447 |
45,000 |
13,481,808 |
| Siokas Grigorios | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.23 |
701,447 |
160,000 |
13,263,361 |
| Siokas Grigorios | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.37 |
388,532 |
145,000 |
8,861,914 |
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
8.76%
3.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):